Towards personalized tumor markers

por Vathany Kulasingam, Ioannis Prassas, Eleftherios P. Diamandis
Publicado 2017

Comparison of two multiplexed technologies for profiling >1,000 serum proteins that may associate with tumor burden [version 1; peer review: 2 approved, 1 approved with reservation...

por Annie Ren, Ioannis Prassas, Vijithan Sugumar, Antoninus Soosaipillai, Marcus Bernardini, Eleftherios P Diamandis, Vathany Kulasingam
Publicado 2021

Novel Outcome Biomarkers Identified With Targeted Proteomic Analyses of Plasma From Critically Ill Coronavirus Disease 2019 Patients

por Douglas D. Fraser, MD, PhD, Gediminas Cepinskas, DVM, PhD, Eric K. Patterson, PhD, Marat Slessarev, MD, MSc, Claudio Martin, MD, MSc, Mark Daley, PhD, Maitray A. Patel, BSc, Michael R. Miller, PhD, David B. O’Gorman, PhD, Sean E. Gill, PhD, Guillaume Pare, MD, MSc, Ioannis Prassas, PhD, Eleftherios Diamandis, MD, PhD, on behalf of the Lawson COVID19 Study Team, Robert Arntfield, Ian Ball, Gordon Barkwell, Tracey Bentall, Karen Bosma, Saoirse Cameron, Eileen Campbell, David Carter, Carolina Gillio-Meina, Robert Hegele, Natalya Odoardi, Ram Singh, Kelly Summers, Sue Tereschyn
Publicado 2020